These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
533 related articles for article (PubMed ID: 22036137)
21. The profiles and patterns of detrusor overactivity and their association with overactive bladder symptoms in men with benign prostatic enlargement associated with detrusor overactivity. Shahab N; Seki N; Takahashi R; Kajioka S; Takei M; Yamaguchi A; Naito S Neurourol Urodyn; 2009; 28(8):953-8. PubMed ID: 19260093 [TBL] [Abstract][Full Text] [Related]
22. Correlation of the Overactive Bladder Symptom Score, and the Voiding Diary and Urodynamic Parameters in Patients with Overactive Bladder Syndrome. Song M; Chun JY; Yoo DS; Han JY; Choo MS Low Urin Tract Symptoms; 2014 Sep; 6(3):180-4. PubMed ID: 26663602 [TBL] [Abstract][Full Text] [Related]
23. Correlation between overactive bladder and detrusor overactivity: a retrospective study. Huang TX; Lo TS; Tseng HJ; Lin YH; Liang CC; Hsieh WC Int Urogynecol J; 2023 Apr; 34(4):867-875. PubMed ID: 35751673 [TBL] [Abstract][Full Text] [Related]
24. Urodynamic findings in female diabetic patients with and without overactive bladder symptoms. Ho CH; Tai HC; Yu HJ Neurourol Urodyn; 2010 Mar; 29(3):424-7. PubMed ID: 19283863 [TBL] [Abstract][Full Text] [Related]
25. Useful parameters to predict the presence of detrusor overactivity in male patients with lower urinary tract symptoms. Matsukawa Y; Majima T; Ishida S; Funahashi Y; Kato M; Gotoh M Neurourol Urodyn; 2020 Jun; 39(5):1394-1400. PubMed ID: 32259358 [TBL] [Abstract][Full Text] [Related]
26. OAB score: a clinical model that predicts the probability of presenting overactive detrusor in the urodynamic study. Arribillaga LC; Ledesma M; Montedoro A; Pisano F; Bengió RG Int Braz J Urol; 2018; 44(2):348-354. PubMed ID: 29211399 [TBL] [Abstract][Full Text] [Related]
27. Predictors of short-term overactive bladder symptom improvement after transurethral resection of prostate in men with benign prostatic obstruction. Zhao YR; Liu WZ; Guralnick M; Niu WJ; Wang Y; Sun G; Xu Y Int J Urol; 2014 Oct; 21(10):1035-40. PubMed ID: 24825248 [TBL] [Abstract][Full Text] [Related]
28. The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease. Kabay S; Canbaz Kabay S; Cetiner M; Mestan E; Sevim M; Ayas S; Ozden H; Ozisik Karaman H Urology; 2016 Jan; 87():76-81. PubMed ID: 26436213 [TBL] [Abstract][Full Text] [Related]
29. Hypersensitive or Detrusor Overactivity: Which is Associated with Filling Symptoms in Female Bladder Outlet Obstructed Patients. Zhang J; Cao M; Chen Y; Liang W; Liang Y Urol J; 2019 Jun; 16(3):285-288. PubMed ID: 30882167 [TBL] [Abstract][Full Text] [Related]
30. Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom. Kim JC; Park EY; Hong SH; Seo SI; Park YH; Hwang TK Int J Urol; 2005 Oct; 12(10):875-80. PubMed ID: 16323980 [TBL] [Abstract][Full Text] [Related]
31. The impact of tension-free vaginal tape on overactive bladder symptoms in women with stress urinary incontinence: significance of detrusor overactivity. Choe JH; Choo MS; Lee KS J Urol; 2008 Jan; 179(1):214-9. PubMed ID: 18001792 [TBL] [Abstract][Full Text] [Related]
32. Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment. Palleschi G; Pastore AL; Stocchi F; Bova G; Inghilleri M; Sigala S; Carbone A Clin Neuropharmacol; 2006; 29(4):220-9. PubMed ID: 16855424 [TBL] [Abstract][Full Text] [Related]
33. Are patients with bladder oversensitivity different from those with urodynamically proven detrusor overactivity in female overactive bladder syndrome? Chen SL; Ng SC; Huang YH; Chen GD J Chin Med Assoc; 2017 Oct; 80(10):644-650. PubMed ID: 28757173 [TBL] [Abstract][Full Text] [Related]
34. Association of symptoms with urodynamic findings in men with overactive bladder syndrome. Al-Zahrani AA; Gajewski JB BJU Int; 2012 Dec; 110(11 Pt C):E891-5. PubMed ID: 22928556 [TBL] [Abstract][Full Text] [Related]
35. [Urodynamic classification of male patients with symptoms of overactive bladder and the outcome classification]. Wang T; Xu KX; Zhang WY; Hu H; Zhang XW; Wang HR; Liu XH; Chen JW; Zhang XP Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):1048-1051. PubMed ID: 31848502 [TBL] [Abstract][Full Text] [Related]
36. Effect of holmium laser enucleation of prostate on overactive bladder symptoms and urodynamic parameters: a prospective study. Kwon O; Lee HE; Bae J; Oh JK; Oh SJ Urology; 2014 Mar; 83(3):581-5. PubMed ID: 24373317 [TBL] [Abstract][Full Text] [Related]
37. Use of near infrared spectroscopy as an alternative to videourodynamics to detect detrusor overactivity in women with the overactive bladder syndrome. Mastoroudes H; Giarenis I; Vella M; Srikrishna S; Robinson D; Cardozo L; Karrouze I; Campbell A; Macnab A Urology; 2012 Sep; 80(3):547-50. PubMed ID: 22840868 [TBL] [Abstract][Full Text] [Related]
38. Clinical and urodynamic differences among women with overactive bladder according to the presence of detrusor overactivity. Jeong SJ; Lee SC; Jeong CW; Hong SK; Byun SS; Lee SE Int Urogynecol J; 2013 Feb; 24(2):255-61. PubMed ID: 22588142 [TBL] [Abstract][Full Text] [Related]
39. A prospective randomized trial comparing the use of tolterodine or weighted vaginal cones in women with overactive bladder syndrome. Yüce T; Dökmeci F; Çetinkaya ŞE Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():91-7. PubMed ID: 26720597 [TBL] [Abstract][Full Text] [Related]
40. Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause? Matarazzo MG; Caruso S; Giunta G; Valenti G; Sarpietro G; Cianci A Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():75-79. PubMed ID: 29367168 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]